NEW: HHS official Alicia Jackson publicly endorsed a federal health policy change on hormone therapies while owning stock in a company that provides access to menopause treatments.
After our reporting, a watchdog group is urging an investigation.
propublica.org/article/hhs-ali…
#News #HHS #Health #Women #Government #Stock #Ethics
Ethics Watchdog Urges Investigation Into Top Health Official, Alleging Conflict of Interest Over Hormone Therapy Policy
The complaint follows a ProPublica investigation that found Alicia Jackson, a high-ranking federal health official, publicly endorsed a change in hormone therapy policy while owning stock in a company that provides access to menopause treatments.Corey G. Johnson (ProPublica)